Leadership Through Research Collaboration Is Reflected In Articles Published In Alzheimer's Association Journal
CHICAGO, July 19, 2013 /PRNewswire-USNewswire/ -- A global, collaborative research effort based on public-private partnerships, similar to the projects in the 1950s and 1960s that successfully reduced polio worldwide, will be essential in advancing the prevention, diagnosis, and treatment of Alzheimer's disease, according to two articles written by leaders of the Alzheimer's Association and published in the July 2013 issue of Alzheimer's & Dementia: The Journal of the Alzheimer's Association.
The authors call for the research community to work in partnership to accelerate Alzheimer's and dementia research through funding high-impact research, collaborating with appropriate partners, and convening top experts to answer important research questions, among other tactics.
"A coordinated global research agenda is needed to drive the advances necessary to improve the lives of the millions worldwide with Alzheimer's disease now and to meet the U.S. National Alzheimer's Plan's goal of preventing and effectively treating Alzheimer's disease by 2025," said Maria Carrillo, Ph.D., Alzheimer's Association vice president of Medical and Scientific Relations. "This coordination is essential when considering the limited resources currently allocated to Alzheimer's and dementia research and the magnitude of the impact of the disease in individuals, families and societies."
"The development of tangible interventions for the detection, cure and care of those at-risk or affected with Alzheimer's is our foremost task," Carrillo writes in an editorial. "We must improve the process by which we manage the research enterprise. The field must articulate a unified and integrated vision. The need for new multi-national partnerships is critical."A third article in the journal presents modifications to guidelines established collaboratively by the Alzheimer's Association and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) for brain amyloid imaging using positron emission tomography (PET) as a tool for Alzheimer's diagnosis.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV